XIFAXAN (Salix Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the XIFAXAN drug offered from Salix Pharmaceuticals, Inc.. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Salix Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | rifaximin |
| SUBSTANCE NAME: | RIFAXIMIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-07-25 |
| END MARKETING DATE: | 0000-00-00 |
XIFAXAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | XIFAXAN from Salix Pharmaceuticals, Inc. |
| LABELER NAME: | Salix Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2004-07-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65649-301_e5534721-2b1e-4375-9520-265699493065 |
| PRODUCT NDC: | 65649-301 |
| APPLICATION NUMBER: | NDA021361 |
Other RIFAXIMIN Pharmaceutical Manufacturers / Labelers:
